Active	Status	Sponsor type	Region	Phase	Filter
5 Active 9 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Huang, Chun Hou
ACTIVE, NCT04882345: Almonertinib Treats Advanced NSCLC Patients With EGFR Mutations Who Are Safety Intolerant After Osimertinib Treatment	Not yet recruiting	2	40	NA	Almonertinib, HS-10296	Shanghai Chest Hospital, Jiangsu Hansoh Pharmaceutical Co., Ltd.	Lung Cancer, EGFR Gene Mutation	01/24	01/24
LO, Shu-Fen
No trials found
Kao, Li-Cheng
No trials found